172 related articles for article (PubMed ID: 11911408)
21. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
22. Second solid malignancies after combined modality therapy for Hodgkin's disease.
Doria R; Holford T; Farber LR; Prosnitz LR; Cooper DL
J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
[TBL] [Abstract][Full Text] [Related]
23. [Second primary tumors in patients treated at an early age for Hodgkin's disease; consequences for the follow-up].
Aleman BM; Klokman WJ; van Leeuwen FE
Ned Tijdschr Geneeskd; 2000 Aug; 144(32):1517-20. PubMed ID: 10949633
[TBL] [Abstract][Full Text] [Related]
24. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
25. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
Dores GM; Metayer C; Curtis RE; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; van Leeuwen FE; Holowaty EJ; Andersson M; Wiklund T; Joensuu T; van't Veer MB; Stovall M; Gospodarowicz M; Travis LB
J Clin Oncol; 2002 Aug; 20(16):3484-94. PubMed ID: 12177110
[TBL] [Abstract][Full Text] [Related]
26. Second malignancy complicating Hodgkin's disease.
Tawil E; Mercier JP
J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
[TBL] [Abstract][Full Text] [Related]
27. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
[TBL] [Abstract][Full Text] [Related]
28. [Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases].
Cutuli B; de La Rochefordière A; Dhermain F; Borel C; Graic Y; de Lafontan B; Dilhyudy JM; Mignotte H; Tessier E; Tortochaux J; N'Guyen T; Bey P; Le Mevel-Le Pourhier A; Arriagada R
Cancer Radiother; 1997; 1(4):300-6. PubMed ID: 9435820
[TBL] [Abstract][Full Text] [Related]
29. Second malignant neoplasms in patients treated for Hodgkin's disease with radiotherapy or radiotherapy and chemotherapy.
Nelson DF; Cooper S; Weston MG; Rubin P
Cancer; 1981 Dec; 48(11):2386-93. PubMed ID: 7296488
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer following Hodgkin's Disease: the experience of the University of Florence.
Meattini I; Livi L; Saieva C; Marrazzo L; Rampini A; Iermano C; Papi MG; Detti B; Scoccianti S; Biti G
Breast J; 2010; 16(3):290-6. PubMed ID: 20210800
[TBL] [Abstract][Full Text] [Related]
31. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
Salloum E; Doria R; Schubert W; Zelterman D; Holford T; Roberts KB; Farber LR; Kiehl RK; Cardinale J; Cooper DL
J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
[TBL] [Abstract][Full Text] [Related]
32. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
Glanzmann C; Veraguth A; Lütolf UM
Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
[TBL] [Abstract][Full Text] [Related]
33. Late sequelae of treatment of Hodgkin's disease.
DeVita VT
Curr Opin Oncol; 1997 Sep; 9(5):428-31. PubMed ID: 9327220
[TBL] [Abstract][Full Text] [Related]
34. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
[TBL] [Abstract][Full Text] [Related]
35. Second malignancies following treatment in non-Hodgkin's lymphoma.
Ellis M; Lishner M
Leuk Lymphoma; 1993 Mar; 9(4-5):337-42. PubMed ID: 8348069
[TBL] [Abstract][Full Text] [Related]
36. Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
J Clin Oncol; 1986 Jun; 4(6):830-7. PubMed ID: 3711960
[TBL] [Abstract][Full Text] [Related]
37. Second malignancies following treatment for Hodgkin's disease: a Greek experience.
Economopoulos T; Stathakis N; Alexopoulos C; Pavlidis N; Constantinidou M; Briassoulis E; Papageorgiou E; Dervenoulas J; Pappa V; Vaslamatzis M
Haematologica; 1994; 79(3):273-6. PubMed ID: 7926979
[TBL] [Abstract][Full Text] [Related]
38. Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution.
Biti G; Cellai E; Magrini SM; Papi MG; Ponticelli P; Boddi V
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):25-31. PubMed ID: 8175441
[TBL] [Abstract][Full Text] [Related]
39. [Clinical characteristics and therapy outcome in children with stage IV Hodgkin's lymphoma--the experience of two oncological centres].
Bień E; Stachowicz-Stencel T; Zawitkowska-Klaczyńska J; Adamkiewicz-Drozyńska E; Odój T; Połczyńska K; Mitura-Lesiuk M; Stefanowicz J; Sierota D; Szołkiewicz A; Birkholz D; Hennig M; Kowalczyk JR; Balcerska A
Med Wieku Rozwoj; 2006; 10(3 Pt 1):631-8. PubMed ID: 17317894
[TBL] [Abstract][Full Text] [Related]
40. Hodgkin's disease terminating in acute leukaemia: report of seven cases.
Wolf MM; Cooper IA; Ding JC
Aust N Z J Med; 1979 Aug; 9(4):398-402. PubMed ID: 292379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
